PURA VIDA INVESTMENTS, LLC - Q3 2018 holdings

Add to watchlist

$475 Million is the total value of PURA VIDA INVESTMENTS, LLC's 106 reported holdings in Q3 2018. The portfolio turnover from Q2 2018 to Q3 2018 was 119.6% .

All

			Value		Shares		↓ Weighting
SPY	Buy	SPDR S&P 500 ETF TRput	$62,505,000	+1743.3%	215,000	+1620.0%	13.15%	+867.5%
IWM	Buy	ISHARES TRput	$37,924,000	+414.6%	225,000	+400.0%	7.98%	+170.1%
LIVN	Buy	LIVANOVA PLCcall	$26,034,000	+33.7%	210,000	+7.7%	5.48%	-29.8%
XLV	Buy	SELECT SECTOR SPDR TRput	$11,894,000	+137.5%	125,000	+108.3%	2.50%	+24.7%
ICUI	Buy	ICU MED INC	$11,683,000	+65.8%	41,319	+72.2%	2.46%	-13.0%
INSP	Buy	INSPIRE MED SYS INC	$10,246,000	+43.5%	243,493	+21.6%	2.16%	-24.7%
MDT	New	MEDTRONIC PLCcall	$9,837,000	–	100,000	+100.0%	2.07%	–
BSX	Buy	BOSTON SCIENTIFIC CORP	$9,738,000	+1090.5%	252,925	+911.7%	2.05%	+524.7%
NVO	New	NOVO-NORDISK A Scall	$9,428,000	–	200,000	+100.0%	1.98%	–
ICUI	Sell	ICU MED INCcall	$9,048,000	-12.0%	32,000	-8.6%	1.90%	-53.8%
LIVN	Buy	LIVANOVA PLC	$8,786,000	+25.7%	70,871	+1.2%	1.85%	-34.0%
FXH	New	FIRST TR EXCHANGE TRADED FDput	$8,488,000	–	100,000	+100.0%	1.79%	–
MDT	Buy	MEDTRONIC PLC	$7,971,000	+86.2%	81,027	+62.1%	1.68%	-2.3%
ABT	New	ABBOTT LABScall	$7,336,000	–	100,000	+100.0%	1.54%	–
DXCM	New	DEXCOM INCcall	$7,152,000	–	50,000	+100.0%	1.50%	–
ZBH	New	ZIMMER BIOMET HLDGS INCcall	$6,574,000	–	50,000	+100.0%	1.38%	–
DXCM	Buy	DEXCOM INC	$6,517,000	+174.4%	45,560	+82.2%	1.37%	+44.0%
NSTG	Buy	NANOSTRING TECHNOLOGIES INC	$6,356,000	+134.5%	356,494	+79.9%	1.34%	+23.1%
AMGN	New	AMGEN INC	$6,296,000	–	30,373	+100.0%	1.32%	–
AMGN	New	AMGEN INCput	$6,219,000	–	30,000	+100.0%	1.31%	–
STAA	Buy	STAAR SURGICAL CO	$5,835,000	+88.2%	121,556	+21.6%	1.23%	-1.2%
VRAY	Buy	VIEWRAY INC	$5,811,000	+93.8%	620,839	+43.3%	1.22%	+1.7%
XENT	New	INTERSECT ENT INCcall	$5,750,000	–	200,000	+100.0%	1.21%	–
BRKS	New	BROOKS AUTOMATION INC NEW	$5,699,000	–	162,676	+100.0%	1.20%	–
CNC	New	CENTENE CORP DEL	$5,488,000	–	37,905	+100.0%	1.15%	–
OFIX	New	ORTHOFIX MED INC	$5,264,000	–	91,058	+100.0%	1.11%	–
ZBH	New	ZIMMER BIOMET HLDGS INC	$5,259,000	–	40,000	+100.0%	1.11%	–
WMGI	Buy	WRIGHT MED GROUP N V	$5,142,000	+164.1%	177,178	+136.2%	1.08%	+38.7%
ESTA	New	ESTABLISHMENT LABS HLDGS INC	$5,010,000	–	207,882	+100.0%	1.05%	–
SMH	New	VANECK VECTORS ETF TRput	$4,790,000	–	45,000	+100.0%	1.01%	–
XBI	Sell	SPDR SER TRput	$4,794,000	-49.6%	50,000	-50.0%	1.01%	-73.6%
SYNH	Buy	SYNEOS HEALTH INCcl a	$4,697,000	+43.1%	91,120	+30.2%	0.99%	-24.9%
BAX	Buy	BAXTER INTL INC	$4,625,000	+56.6%	60,000	+50.0%	0.97%	-17.8%
AERI	New	AERIE PHARMACEUTICALS INCcall	$4,616,000	–	75,000	+100.0%	0.97%	–
REGN	New	REGENERON PHARMACEUTICALScall	$4,040,000	–	10,000	+100.0%	0.85%	–
AZN	New	ASTRAZENECA PLCcall	$3,957,000	–	100,000	+100.0%	0.83%	–
EHC	New	ENCOMPASS HEALTH CORPput	$3,898,000	–	50,000	+100.0%	0.82%	–
KIDS	Buy	ORTHOPEDIATRICS CORP	$3,695,000	+86.4%	100,834	+35.6%	0.78%	-2.1%
AMRN	New	AMARIN CORP PLCspons adr new	$3,661,000	–	225,000	+100.0%	0.77%	–
ITCI	New	INTRA CELLULAR THERAPIES INCput	$3,648,000	–	168,100	+100.0%	0.77%	–
OMCL	New	OMNICELL COMput	$3,595,000	–	50,000	+100.0%	0.76%	–
ADMA	Buy	ADMA BIOLOGICS INC	$3,548,000	+142.0%	571,317	+75.8%	0.75%	+26.9%
ELAN	New	ELANCO ANIMAL HEALTH INC	$3,489,000	–	100,000	+100.0%	0.73%	–
NVRO		NEVRO CORPput	$3,420,000	-28.6%	60,000	0.0%	0.72%	-62.6%
NVTRQ	New	NUVECTRA CORPcall	$3,297,000	–	150,000	+100.0%	0.69%	–
GMED	Sell	GLOBUS MED INCcl a	$3,264,000	-4.2%	57,500	-14.8%	0.69%	-49.7%
AMRN	New	AMARIN CORP PLCput	$3,254,000	–	200,000	+100.0%	0.68%	–
TNDM	New	TANDEM DIABETES CARE INC	$3,253,000	–	75,933	+100.0%	0.68%	–
TMO	New	THERMO FISHER SCIENTIFIC INCput	$3,051,000	–	12,500	+100.0%	0.64%	–
VAR	New	VARIAN MED SYS INCput	$2,798,000	–	25,000	+100.0%	0.59%	–
AVNS	New	AVANOS MED INC	$2,778,000	–	40,560	+100.0%	0.58%	–
LLY	New	LILLY ELI & COcall	$2,683,000	–	25,000	+100.0%	0.56%	–
TFX	New	TELEFLEX INCORPORATEDput	$2,661,000	–	10,000	+100.0%	0.56%	–
NVTRQ	Buy	NUVECTRA CORP	$2,519,000	+88.8%	114,616	+76.3%	0.53%	-0.9%
ZGNX		ZOGENIX INCcall	$2,480,000	+12.2%	50,000	0.0%	0.52%	-41.1%
XENT	Buy	INTERSECT ENT INC	$2,401,000	-11.6%	83,527	+15.2%	0.50%	-53.6%
ATRC	New	ATRICURE INC	$2,370,000	–	67,670	+100.0%	0.50%	–
MRTX	New	MIRATI THERAPEUTICS INCput	$2,355,000	–	50,000	+100.0%	0.50%	–
RCM	New	R1 RCM INC	$2,307,000	–	227,109	+100.0%	0.48%	–
ZGNX	Sell	ZOGENIX INC	$2,218,000	+10.8%	44,718	-1.2%	0.47%	-41.8%
ALKS	New	ALKERMES PLCcall	$2,122,000	–	50,000	+100.0%	0.45%	–
ALXN	Buy	ALEXION PHARMACEUTICALS INC	$2,102,000	+69.2%	15,124	+51.2%	0.44%	-11.2%
TSRO	New	TESARO INC	$1,980,000	–	50,747	+100.0%	0.42%	–
PBH	New	PRESTIGE CONSMR HEALTHCARE Iput	$1,895,000	–	50,000	+100.0%	0.40%	–
IMGN	New	IMMUNOGEN INCcall	$1,894,000	–	200,000	+100.0%	0.40%	–
VCRA	New	VOCERA COMMUNICATIONS INC	$1,852,000	–	50,622	+100.0%	0.39%	–
MYL	Sell	MYLAN NVcall	$1,830,000	-32.5%	50,000	-33.3%	0.38%	-64.5%
EXEL	New	EXELIXIS INCcall	$1,772,000	–	100,000	+100.0%	0.37%	–
NTRA	New	NATERA INC	$1,697,000	–	70,871	+100.0%	0.36%	–
FLDM	New	FLUIDIGM CORP DEL	$1,685,000	–	225,000	+100.0%	0.35%	–
SPPI		SPECTRUM PHARMACEUTICALS INCput	$1,680,000	-19.8%	100,000	0.0%	0.35%	-58.0%
PACB	New	PACIFIC BIOSCIENCES CALIF IN	$1,643,000	–	303,734	+100.0%	0.35%	–
VRAY	Sell	VIEWRAY INCcall	$1,638,000	+18.4%	175,000	-12.5%	0.34%	-37.8%
AXDX		ACCELERATE DIAGNOSTICS INCcall	$1,607,000	+2.9%	70,000	0.0%	0.34%	-46.0%
QGEN	Sell	QIAGEN NVcall	$1,515,000	-58.1%	40,000	-60.0%	0.32%	-78.0%
IVC	Sell	INVACARE CORP	$1,455,000	-36.3%	100,000	-18.5%	0.31%	-66.6%
NSTG	New	NANOSTRING TECHNOLOGIES INCcall	$1,337,000	–	75,000	+100.0%	0.28%	–
ARVN	New	ARVINAS INC	$1,265,000	–	75,000	+100.0%	0.27%	–
BSTC	New	BIOSPECIFICS TECHNOLOGIES CO	$1,179,000	–	20,160	+100.0%	0.25%	–
ARAY	Sell	ACCURAY INCcall	$1,125,000	-50.1%	250,000	-54.5%	0.24%	-73.8%
FLDM	New	FLUIDIGM CORP DELcall	$1,124,000	–	150,000	+100.0%	0.24%	–
PRQR	Sell	PROQR THRAPEUTICS N V	$1,099,000	-44.5%	56,803	-79.1%	0.23%	-70.9%
GRTS	New	GRITSTONE ONCOLOGY INC	$1,068,000	–	75,000	+100.0%	0.22%	–
CLLS	Buy	CELLECTIS S Aspon ads	$1,000,000	+1.0%	35,437	+1.2%	0.21%	-47.1%
RIGL	Sell	RIGEL PHARMACEUTICALS INC	$971,000	-37.6%	302,489	-45.0%	0.20%	-67.3%
OBSV	Sell	OBSEVA SA	$913,000	-33.0%	50,622	-43.8%	0.19%	-64.8%
SELB	New	SELECTA BIOSCIENCES INC	$905,000	–	58,205	+100.0%	0.19%	–
SPPI	New	SPECTRUM PHARMACEUTICALS INC	$840,000	–	50,000	+100.0%	0.18%	–
SNDX	New	SYNDAX PHARMACEUTICALS INCcall	$808,000	–	100,000	+100.0%	0.17%	–
SNDX	New	SYNDAX PHARMACEUTICALS INC	$808,000	–	100,000	+100.0%	0.17%	–
MDGL	Sell	MADRIGAL PHARMACEUTICALS INC	$793,000	-78.4%	3,702	-71.7%	0.17%	-88.6%
OTIC	Buy	OTONOMY INC	$791,000	+148.0%	287,657	+247.4%	0.17%	+29.7%
BCRX	New	BIOCRYST PHARMACEUTICALS INC	$773,000	–	101,245	+100.0%	0.16%	–
DRNA	New	DICERNA PHARMACEUTICALS INC	$772,000	–	50,622	+100.0%	0.16%	–
CPRX	Buy	CATALYST PHARMACEUTICALS INC	$765,000	+63.5%	202,489	+35.0%	0.16%	-14.4%
INCY		INCYTE CORPcall	$691,000	+3.1%	10,000	0.0%	0.14%	-46.1%
OCUL	New	OCULAR THERAPEUTIX INC	$592,000	–	86,058	+100.0%	0.12%	–
YMAB	New	Y MABS THERAPEUTICS INC	$594,000	–	22,350	+100.0%	0.12%	–
FOLD	New	AMICUS THERAPEUTICS INC	$551,000	–	45,560	+100.0%	0.12%	–
ITCI		INTRA CELLULAR THERAPIES INCcall	$543,000	+22.9%	25,000	0.0%	0.11%	-35.6%
MTEM	New	MOLECULAR TEMPLATES INC	$522,000	–	96,908	+100.0%	0.11%	–
EIGR	Buy	EIGER BIOPHARMACEUTICALS INC	$486,000	-0.4%	40,498	+1.2%	0.10%	-48.0%
ACETQ	New	ACETO CORP	$478,000	–	211,624	+100.0%	0.10%	–
VRCA	New	VERRICA PHARMACEUTICALS INC	$325,000	–	20,000	+100.0%	0.07%	–
CLSD	New	CLEARSIDE BIOMEDICAL INC	$311,000	–	50,622	+100.0%	0.06%	–
UROV	New	UROVANT SCIENCES LTD	$120,000	–	10,000	+100.0%	0.02%	–
FOMX	Exit	FOAMIX PHARMACEUTICALS LTD	$0	–	-24,100	-100.0%	-0.05%	–
CYTK	Exit	CYTOKINETICS INCcall	$0	–	-24,600	-100.0%	-0.08%	–
ITCI	Exit	INTRA CELLULAR THERAPIES INC	$0	–	-20,000	-100.0%	-0.14%	–
ARDX	Exit	ARDELYX INC	$0	–	-100,000	-100.0%	-0.15%	–
KMPH	Exit	KEMPHARM INC	$0	–	-60,000	-100.0%	-0.16%	–
VKTX	Exit	VIKING THERAPEUTICS INC	$0	–	-47,100	-100.0%	-0.18%	–
GBT	Exit	GLOBAL BLOOD THERAPEUTICS INcall	$0	–	-10,300	-100.0%	-0.19%	–
STAA	Exit	STAAR SURGICAL COcall	$0	–	-17,500	-100.0%	-0.22%	–
XNCR	Exit	XENCOR INC	$0	–	-15,000	-100.0%	-0.22%	–
TGTX	Exit	TG THERAPEUTICS INC	$0	–	-50,000	-100.0%	-0.26%	–
GERN	Exit	GERON CORPput	$0	–	-200,000	-100.0%	-0.28%	–
XENE	Exit	XENON PHARMACEUTICALS INC	$0	–	-75,000	-100.0%	-0.28%	–
MOTS	Exit	MOTUS GI HLDGS INC	$0	–	-100,000	-100.0%	-0.29%	–
FOLD	Exit	AMICUS THERAPEUTICS INCcall	$0	–	-50,000	-100.0%	-0.31%	–
BLUE	Exit	BLUEBIRD BIO INC	$0	–	-5,000	-100.0%	-0.32%	–
VKTX	Exit	VIKING THERAPEUTICS INCput	$0	–	-100,000	-100.0%	-0.38%	–
RCKT	Exit	ROCKET PHARMACEUTICALS INC	$0	–	-51,459	-100.0%	-0.40%	–
AKRXQ	Exit	AKORN INCcall	$0	–	-67,900	-100.0%	-0.45%	–
ANGO	Exit	ANGIODYNAMICS INC	$0	–	-50,842	-100.0%	-0.45%	–
TTOO	Exit	T2 BIOSYSTEMS INC	$0	–	-150,000	-100.0%	-0.46%	–
IMMU	Exit	IMMUNOMEDICS INC	$0	–	-50,400	-100.0%	-0.48%	–
COLL	Exit	COLLEGIUM PHARMACEUTICAL INC	$0	–	-52,219	-100.0%	-0.50%	–
CHRS	Exit	COHERUS BIOSCIENCES INCput	$0	–	-97,500	-100.0%	-0.55%	–
AVRO	Exit	AVROBIO INC	$0	–	-52,500	-100.0%	-0.60%	–
CORT	Exit	CORCEPT THERAPEUTICS INCput	$0	–	-100,200	-100.0%	-0.63%	–
ZGNX	Exit	ZOGENIX INCput	$0	–	-36,100	-100.0%	-0.64%	–
MRK	Exit	MERCK & CO. INC	$0	–	-30,000	-100.0%	-0.73%	–
CSII	Exit	CARDIOVASCULAR SYS INC DELcall	$0	–	-58,000	-100.0%	-0.75%	–
CARA	Exit	CARA THERAPEUTICS INCcall	$0	–	-100,000	-100.0%	-0.77%	–
HOLX	Exit	HOLOGIC INCcall	$0	–	-50,000	-100.0%	-0.80%	–
GKOS	Exit	GLAUKOS CORP	$0	–	-50,000	-100.0%	-0.81%	–
SRPT	Exit	SAREPTA THERAPEUTICS INC	$0	–	-16,000	-100.0%	-0.85%	–
GBT	Exit	GLOBAL BLOOD THERAPEUTICS INput	$0	–	-50,000	-100.0%	-0.91%	–
SIEN	Exit	SIENTRA INCcall	$0	–	-125,400	-100.0%	-0.98%	–
VRTX	Exit	VERTEX PHARMACEUTICALS INC	$0	–	-15,000	-100.0%	-1.02%	–
XENT	Exit	INTERSECT ENT INCput	$0	–	-70,000	-100.0%	-1.05%	–
SPPI	Exit	SPECTRUM PHARMACEUTICALS INCcall	$0	–	-130,700	-100.0%	-1.10%	–
SYNH	Exit	SYNEOS HEALTH INCcall	$0	–	-60,000	-100.0%	-1.13%	–
GKOS	Exit	GLAUKOS CORPcall	$0	–	-76,200	-100.0%	-1.24%	–
AGN	Exit	ALLERGAN PLC	$0	–	-20,000	-100.0%	-1.34%	–
ATHN	Exit	ATHENAHEALTH INC	$0	–	-21,000	-100.0%	-1.34%	–
HOLX	Exit	HOLOGIC INC	$0	–	-87,500	-100.0%	-1.39%	–
SIEN	Exit	SIENTRA INC	$0	–	-183,900	-100.0%	-1.44%	–
GWPH	Exit	GW PHARMACEUTICALS PLCcall	$0	–	-30,000	-100.0%	-1.68%	–
MTD	Exit	METTLER TOLEDO INTERNATIONALput	$0	–	-10,000	-100.0%	-2.32%	–
CNC	Exit	CENTENE CORP DELcall	$0	–	-50,000	-100.0%	-2.47%	–
BSX	Exit	BOSTON SCIENTIFIC CORPcall	$0	–	-200,000	-100.0%	-2.62%	–
ATHN	Exit	ATHENAHEALTH INCcall	$0	–	-72,500	-100.0%	-4.62%	–

Original filings

The following EDGAR filing(s) were analyzed to create this report:

View 13F-HR/A filed 2021-02-11

Signatures

The EDGAR filing(s) were signed by:

Alyssa Romano — Chief Compliance Officer and Chief Financial Officer

Top long-term holdings

Name	Quarters owned	Latest quarter owned	Max weighting
ICU MED INC	26	Q2 2023	4.2%
NANOSTRING TECHNOLOGIES INC	26	Q2 2023	3.3%
VIEWRAY INC	25	Q2 2023	3.2%
LIVANOVA PLC	23	Q3 2023	3.8%
ALEXION PHARMACEUTICALS INC	23	Q1 2021	4.3%
INSPIRE MED SYS INC	22	Q3 2023	3.7%
BOSTON SCIENTIFIC CORP	22	Q3 2022	4.8%
INVACARE CORP	22	Q3 2021	2.8%
ESTABLISHMENT LABS HLDGS INC	21	Q3 2023	5.0%
INTERSECT ENT INC	21	Q2 2021	2.6%

View PURA VIDA INVESTMENTS, LLC's complete holdings history.

Latest significant ownerships (13-D/G)

PURA VIDA INVESTMENTS, LLC Q3 2018 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
	Filed	Shares	Percentage
Stryve Foods Holdings, LLC	April 19, 2023	1,470,649	5.6%
ICAD INC	March 15, 2023	1,277,214	5.0%
ESTABLISHMENT LABS HOLDINGS INC.	February 14, 2023	1,002,767	4.1%
Pulmonx Corp	February 14, 2023	1,216,258	3.2%
Quotient Ltd^{Sold out}	February 14, 2023	0	0.0%
Universe Pharmaceuticals INC^{Sold out}	February 14, 2023	0	0.0%
MedMen Enterprises, Inc.	April 29, 2022	139,755,072	21.4%
INVACARE CORP^{Sold out}	February 14, 2022	0	0.0%
MedAvail Holdings, Inc.	February 14, 2022	714,120	2.2%
TELA Bio, Inc.	February 14, 2022	564,120	3.9%

View PURA VIDA INVESTMENTS, LLC's complete significant-ownership history.

Latest filings

Type	Filed
SC 13G/A	2024-02-14
SC 13G/A	2024-02-14
SC 13G/A	2024-02-14
SC 13G/A	2024-02-14
SC 13G/A	2024-02-14
SC 13G/A	2024-02-14
SC 13G/A	2024-02-14
SC 13G/A	2024-02-14
13F-HR	2024-02-13
SC 13D/A	2023-12-29

View PURA VIDA INVESTMENTS, LLC's complete filings history.

All filings

View complete filings history.

Compare quarters

Issues

The following issues were detected while analyzing the report:

The reported total value is incorrect (475364000.0 != 475368000.0)
The reported has been restated
The reported has been amended

Export PURA VIDA INVESTMENTS, LLC's holdings